Journal
AAPS JOURNAL
Volume 24, Issue 1, Pages -Publisher
SPRINGER
DOI: 10.1208/s12248-021-00675-w
Keywords
central nervous system; blood-brain barrier; drug transporters; lipophilicity; tissue concentrations
Categories
Funding
- Mitsubishi Tanabe Pharma Corporation
- Genentech
- J J
- Merck
- Takeda
Ask authors/readers for more resources
Drug development for the central nervous system (CNS) is challenging due to the complexity of the brain and the blood-brain barrier (BBB). In vitro brain systems have been evaluated, but their translation to human brain concentration profiles is still under development. Linking in vitro-to-in vivo extrapolation (IVIVE) strategies to physiologically based pharmacokinetic (PBPK) models of the brain can improve the prediction of drug concentrations in CNS components. This report summarizes the status and limitations of IVIVE-PBPK-linked models and suggests further research for better prediction of CNS drug disposition.
Drug development for the central nervous system (CNS) is a complex endeavour with low success rates, as the structural complexity of the brain and specifically the blood-brain barrier (BBB) poses tremendous challenges. Several in vitro brain systems have been evaluated, but the ultimate use of these data in terms of translation to human brain concentration profiles remains to be fully developed. Thus, linking up in vitro-to-in vivo extrapolation (IVIVE) strategies to physiologically based pharmacokinetic (PBPK) models of brain is a useful effort that allows better prediction of drug concentrations in CNS components. Such models may overcome some known aspects of inter-species differences in CNS drug disposition. Required physiological (i.e. systems) parameters in the model are derived from quantitative values in each organ. However, due to the inability to directly measure brain concentrations in humans, compound-specific (drug) parameters are often obtained from in silico or in vitro studies. Such data are translated through IVIVE which could be also applied to preclinical in vivo observations. In such exercises, the limitations of the assays and inter-species differences should be adequately understood in order to verify these predictions with the observed concentration data. This report summarizes the state of IVIVE-PBPK-linked models and discusses shortcomings and areas of further research for better prediction of CNS drug disposition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available